CTOs on the Move

Starkey Hearing Technologies

www.starkeyhearingtechnologies.com

 
Starkey Hearing Technologies is much more than the hearing aids we produce. We are in the business of connecting people and changing lives. We believe being able to hear the world and the people around us is as essential to the human experience as breathing. As a world leader in manufacturing and delivering advanced hearing solutions, our goal is to bring people together and make lives richer by empowering individuals to reach their full potential in life. In 1967, William F. Austin founded our company with the simple premise, "Alone we can`t do much. Together, we can change the world." We live ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Millenium Laboratories

Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, is transforming the way health care providers improve clinical outcomes. Millennium helps practitioners provide personalized care to patients in need through its patient-centered research and education initiatives and its ability to respond to evolving health care challenges with advanced technologies.

Sebastian International Inc

Sebastian International Inc is a Woodland Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Dental Marketing Company

The American Dental Company offers member dentists access to sophisticated practice marketing and patient communications products and services with the benefit of group purchase pricing. Mr. Bobrow also serves as Executive Director of Dentists' Climb

Kolltan

Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.

Agennix

Agennix is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Houston, TX. To find more information about Agennix, please visit www.agennix.com